Literature DB >> 27064839

Cancer Incidence and Mortality in Chronic Dialysis Population: A Multicenter Cohort Study.

Chi Yuen Cheung1, Gary C W Chan, Siu Kim Chan, Flora Ng, Man Fai Lam, Sunny S H Wong, Wai Leung Chak, Ka Foon Chau, Sing Leung Lui, Wai Kei Lo, Sydney C W Tang.   

Abstract

BACKGROUND: Different studies in the past have shown that the risk of cancer development is increased in chronic dialysis patients. However, data concerning the cancer risk in Asian dialysis patients was scarce. More importantly, there was lack of information about the cancer-specific mortality in dialysis patients.
METHODS: A multicenter retrospective cohort study of 6,254 patients who started either chronic peritoneal dialysis or hemodialysis between 1994 and 2014 in 4 renal units in Hong Kong. Patterns of cancer incidence and mortality in our dialysis patients were compared with those of the general population using standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) respectively.
RESULTS: With 14,887 person-years of follow-up, 220 cancers were recorded. The SIR of all cancers was 1.44 (95% CI 1.26-1.65). A trend of an increased SIR was observed in young patients and within the first year of dialysis. Colorectum was the most common site of cancer (20%) while kidney cancer carried the highest risk (SIR 12.28, 95% CI 8.44-17.08). The SMR of all cancers was 0.91 (95% CI 0.72-1.13) and only kidney cancer had higher cancer mortality risk (SMR 4.92, 95% CI 1.80-10.70). SMR was highest in young patients and then decreased with age.
CONCLUSIONS: The incidence of cancers in our chronic dialysis patients was elevated. Our findings of substantially increased risks in young patients, particularly in relation to kidney cancer, suggest that we can adopt a more individualized approach to cancer screening in chronic dialysis patients.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27064839     DOI: 10.1159/000445362

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  16 in total

1.  Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Authors:  Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng
Journal:  Int J Clin Oncol       Date:  2019-06-10       Impact factor: 3.402

2.  The incidence of urinary tract cancers is related to preserved diuresis: a single-center report.

Authors:  Vedran Premuzic; Marija Gamulin; Marijana Coric; Bojan Jelakovic
Journal:  Int Urol Nephrol       Date:  2017-10-16       Impact factor: 2.370

3.  Assessment of Feasibility of Robot-assisted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy.

Authors:  Koichi Nishimura; Hiroki Ishihara; Tsunenori Kondo; Makoto Toguchi; Hironori Fukuda; Hidekazu Tachibana; Daisuke Toki; Kazuhiko Yoshida; Junpei Iizuka; Kazunari Tanabe; Toshio Takagi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

4.  Single-Cell RNA and ATAC Sequencing Reveal Hemodialysis-Related Immune Dysregulation of Circulating Immune Cell Subpopulations.

Authors:  Hongwei Wu; Jingjing Dong; Haiyan Yu; Kang Wang; Weier Dai; Xinzhou Zhang; Nan Hu; Lianghong Yin; Donge Tang; Fanna Liu; Yong Dai
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

5.  Hypertensive nephropathy and cancer: Is it the hypertension, the nephropathy, or both?

Authors:  Sabine Karam
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

6.  Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial.

Authors:  Piero Ruggenenti; Manuel Alfredo Podestà; Matias Trillini; Annalisa Perna; Tobia Peracchi; Nadia Rubis; Davide Villa; Davide Martinetti; Monica Cortinovis; Patrizia Ondei; Carmela Giuseppina Condemi; Carlo Maria Guastoni; Agnese Meterangelis; Antonio Granata; Emanuele Mambelli; Sonia Pasquali; Simonetta Genovesi; Federico Pieruzzi; Silvio Volmer Bertoli; Goffredo Del Rosso; Maurizio Garozzo; Angelo Rigotti; Claudio Pozzi; Salvatore David; Giuseppe Daidone; Giulio Mingardi; Giovanni Mosconi; Andrea Galfré; Giorgio Romei Longhena; Alfonso Pacitti; Antonello Pani; Jorge Hidalgo Godoy; Hans-Joachim Anders; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

7.  Association of TSH Elevation with All-Cause Mortality in Elderly Patients with Chronic Kidney Disease.

Authors:  Mei-Hsing Chuang; Kuo-Meng Liao; Yao-Min Hung; Yi-Chang Chou; Pesus Chou
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

8.  Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy.

Authors:  Martina Taborelli; Federica Toffolutti; Stefania Del Zotto; Elena Clagnan; Lucrezia Furian; Pierluca Piselli; Franco Citterio; Loris Zanier; Giuliano Boscutti; Diego Serraino
Journal:  BMC Nephrol       Date:  2019-03-28       Impact factor: 2.388

Review 9.  The effect of chronic kidney disease on T cell alloimmunity.

Authors:  Pamela D Winterberg; Mandy L Ford
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

10.  Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).

Authors:  Paolo Pedrazzoli; Nicola Silvestris; Antonio Santoro; Simona Secondino; Oronzo Brunetti; Vito Longo; Elena Mancini; Sara Mariucci; Teresa Rampino; Sara Delfanti; Silvia Brugnatelli; Saverio Cinieri
Journal:  ESMO Open       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.